FDMT vs MSFT: Which Stock is Better?
Side-by-side comparison of 4D Molecular Therapeutics Inc and Microsoft Corp in 2026
FDMT
4D Molecular Therapeutics Inc
$8.92
MSFT
Microsoft Corp
$410.37
Key Metrics Comparison
| Metric | FDMT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $483.36M | N/A | FDMT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 29.0% | 14.9% | FDMT |
| Gross Margin | -148295.8% | 68.8% | MSFT |
Analyze FDMT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is FDMT or MSFT a better investment?
Comparing FDMT and MSFT: 4D Molecular Therapeutics Inc has a market cap of $483.36M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between FDMT and MSFT?
FDMT (4D Molecular Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: FDMT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: FDMT or MSFT?
FDMT has higher revenue growth at 29.0% vs 14.9% for MSFT.
Which company is more profitable: FDMT or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to -148295.8% for FDMT.
Which is the larger company: FDMT or MSFT?
4D Molecular Therapeutics Inc (FDMT) is larger with a market cap of $483.36M compared to N/A for MSFT.
Should I buy FDMT or MSFT in 2026?
Both FDMT and MSFT have investment merit. FDMT trades at $8.92 while MSFT trades at $410.37. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between FDMT and MSFT stock?
Key differences: Market Cap ($483.36M vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (29.0% vs 14.9%), Gross Margin (-148295.8% vs 68.8%).